Harvard Medical School Postgraduate Medical Education, High-Impact Cancer Research Program (High Impact Cancer Research)
2019 - 2021
East Tennessee State University
Master of Science (Technology and Management)
National Institute of Technology Kurukshetra
Bachelor of Science (Mechanical Engineering)
Erskine College
Master of Divinity
Sam Shrivastava's Skills
Strategic Planning
Biotechnology
Strategy
Management
Business Strategy
Operational Excellence
Driving Results
Cancer
Business Development
Leadership
Sam Shrivastava's Summary
Sam Shrivastava, based in Tampa, Florida, United States, is currently a Founder and Chief Executive Officer at Asha Therapeutics, bringing experience from previous roles at Venn Therapeutics, Ibis Therapeutics, Blackbird BioFinance and Capital Bank. Sam Shrivastava holds a 2019 - 2021 Harvard Medical School Postgraduate Medical Education, High-Impact Cancer Research Program in High Impact Cancer Research @ Harvard Medical School. With a robust skill set that includes Strategic Planning, Biotechnology, Strategy, Management, Business Strategy and more, Sam Shrivastava contributes valuable insights to the industry. Sam Shrivastava has 5 emails and 3 mobile phone numbers on RocketReach.